7 Results for "

finasteride

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "finasteride" in MCE Product Catalog:

4
4 Cited Publications
Art. -Nr.: HY-13635
CAS. Nr.: 98319-26-7
Reinheit:  99.97%
Synonyms: MK-906
Forschungsgebiete:  

Cancer

Finasteride (MK-906) is an orally active and competitive 5α-reductase inhibitor, with an IC50 of 4.2 nM for type II 5α-reductase. Finasteride has approximately a 100-fold greater affinity for type II 5α-reductase enzyme than for the type I enzyme. Finasteride can be used for the research of benign prostatic hyperplasia (BPH) and androgenic alopecia .
loading...
    loading...
Art. -Nr.: HY-13635R
CAS. Nr.: 98319-26-7
Synonyms: MK-906 (Standard)
Forschungsgebiete:  

Cancer

Finasteride (Standard) is the analytical standard of Finasteride. This product is intended for research and analytical applications. Finasteride (MK-906) is a potent and competitive 5α-reductase inhibitor, with an IC50 of 4.2 nM for type II 5α-reductase. Finasteride has approximately a 100-fold greater affinity for type II 5α-reductase enzyme than for the type I enzyme. Finasteride can be used for the research of benign prostatic hyperplasia (BPH) and androgenic alopecia .
loading...
    loading...
Art. -Nr.: HY-13635A
CAS. Nr.: 222989-99-3
Synonyms: MK-906 acetate
Target:  

5 alpha Reductase

Forschungsgebiete:  

Cancer

Finasteride (MK-906) acetate is a potent and competitive 5α-reductase inhibitor, with an IC50 of 4.2 nM for type II 5α-reductase. Finasteride acetate has approximately a 100-fold greater affinity for type II 5α-reductase enzyme than for the type I enzyme. Finasteride acetate can be used for the research of benign prostatic hyperplasia (BPH) and androgenic alopecia .
loading...
    loading...
Art. -Nr.: HY-W739812
CAS. Nr.: 116285-37-1
Synonyms: finasteride carboxylic acid
Target:  

Aldose Reductase

Forschungsgebiete:  

Cancer

Carboxy finasteride is a metabolite of the 5α-reductase inhibitor Finasteride (HY-13635). Finasteride is biotransformed by cytochrome P450 (CYP3A4) and is successively oxidized to Hydroxy finasteride and Carboxy finasteride. Carboxy finasteride is the major metabolite in urine, while Hydroxy finasteride is the major metabolite in plasma .
loading...
    loading...
Art. -Nr.: HY-139349
CAS. Nr.: 154387-61-8
Target:  

Endogenous Metabolite

Forschungsgebiete:  

Others

Finasteride carboxaldehyde (Compound M2) is the metabolite of 5α-reductase inhibitor Finasteride (HY-13635) in human bile and urine .
loading...
    loading...
Art. -Nr.: HY-13635S
CAS. Nr.: 1131342-85-2
Reinheit:  99.13%
Synonyms: MK-906-d9
Finasteride-d9 is deuterium labeled Finasteride. Finasteride (MK-906) is a potent and competitive 5α-reductase inhibitor, with an IC50 of 4.2 nM for type II 5α-reductase. Finasteride has approximately a 100-fold greater affinity for type II 5α-reductase enzyme than for the type I enzyme. Finasteride can be used for the research of benign prostatic hyperplasia (BPH) and androgenic alopecia .
loading...
    loading...
Art. -Nr.: HY-165478
CAS. Nr.: 155651-56-2
Target:  

5 alpha Reductase

Forschungsgebiete:  

Endocrinology

FCE 28260 is an orally active 4-azacyclic 5α-reductase (5αR) inhibitor. FCE 28260 exhibits IC₅₀ values for human 5αR type 1 and 5αR type 2 of 36 and 3.3 nM, respectively, and for human and rat prostates with IC₅₀ values of 16 and 15 nM, respectively. FCE 28260 simultaneously blocks the production of dihydrotestosterone (DHT) in the prostate and peripheral tissues. FCE 28260 can significantly inhibit the induction of prostatic and seminal vesicle hyperplasia by testosterone (T) in rat models, without inhibiting the growth of the prostate in DHT implantation models. FCE 28260 can be used for the studies DHT-dependent diseases such as benign prostatic hyperplasia (BPH) .
loading...
    loading...